Ameen Shafiqul, Siddique Abu Bakkar, Peven Kimberly, Rahman Qazi Sadeq-Ur, Day Louise T, Shabani Josephine, Kc Ashish, Boggs Dorothy, Shamba Donat, Tahsina Tazeen, Rahman Ahmed Ehsanur, Zaman Sojib Bin, Hossain Aniqa Tasnim, Ahmed Anisuddin, Basnet Omkar, Malla Honey, Ruysen Harriet, Blencowe Hannah, Arnold Fred, Requejo Jennifer, Arifeen Shams El, Lawn Joy E
Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68 Shahid Tajuddin Ahmed Sarani, Mohakhali, Dhaka, Bangladesh.
Centre for Maternal, Adolescent, Reproductive & Child Health (MARCH), London School of Hygiene & Tropical Medicine, London, UK.
BMC Pregnancy Childbirth. 2021 Mar 26;21(Suppl 1):238. doi: 10.1186/s12884-020-03425-6.
Population-based household surveys, notably the Demographic and Health Surveys (DHS) and Multiple Indicator Cluster Surveys (MICS), remain the main source of maternal and newborn health data for many low- and middle-income countries. As part of the Every Newborn Birth Indicators Research Tracking in Hospitals (EN-BIRTH) study, this paper focuses on testing validity of measurement of maternal and newborn indicators around the time of birth (intrapartum and postnatal) in survey-report.
EN-BIRTH was an observational study testing the validity of measurement for selected maternal and newborn indicators in five secondary/tertiary hospitals in Bangladesh, Nepal and Tanzania, conducted from July 2017 to July 2018. We compared women's report at exit survey with the gold standard of direct observation or verification from clinical records for women with vaginal births. Population-level validity was assessed by validity ratios (survey-reported coverage: observer-assessed coverage). Individual-level accuracy was assessed by sensitivity, specificity and percent agreement. We tested indicators already in DHS/MICS as well as indicators with potential to be included in population-based surveys, notably the first validation for small and sick newborn care indicators.
33 maternal and newborn indicators were evaluated. Amongst nine indicators already present in DHS/MICS, validity ratios for baby dried or wiped, birthweight measured, low birthweight, and sex of baby (female) were between 0.90-1.10. Instrumental birth, skin-to-skin contact, and early initiation of breastfeeding were highly overestimated by survey-report (2.04-4.83) while umbilical cord care indicators were massively underestimated (0.14-0.22). Amongst 24 indicators not currently in DHS/MICS, two newborn contact indicators (kangaroo mother care 1.00, admission to neonatal unit 1.01) had high survey-reported coverage amongst admitted newborns and high sensitivity. The remaining indicators did not perform well and some had very high "don't know" responses.
Our study revealed low validity for collecting many maternal and newborn indicators through an exit survey instrument, even with short recall periods among women with vaginal births. Household surveys are already at risk of overload, and some specific clinical care indicators do not perform well and may be under-powered. Given that approximately 80% of births worldwide occur in facilities, routine registers should also be explored to track coverage of key maternal and newborn health interventions, particularly for clinical care.
以人群为基础的家庭调查,尤其是人口与健康调查(DHS)和多指标类集调查(MICS),仍然是许多低收入和中等收入国家孕产妇和新生儿健康数据的主要来源。作为“医院新生儿出生指标研究跟踪”(EN-BIRTH)研究的一部分,本文重点测试调查报告中出生时(分娩期和产后)孕产妇和新生儿指标测量的有效性。
EN-BIRTH是一项观察性研究,于2017年7月至2018年7月在孟加拉国、尼泊尔和坦桑尼亚的五家二级/三级医院测试选定的孕产妇和新生儿指标测量的有效性。我们将出院调查中妇女的报告与阴道分娩妇女的直接观察或临床记录核实的金标准进行比较。通过有效性比率(调查报告的覆盖率:观察者评估的覆盖率)评估人群水平上的有效性。通过敏感性、特异性和一致性百分比评估个体水平上的准确性。我们测试了DHS/MICS中已有的指标以及有可能纳入基于人群调查的指标,特别是对小病弱新生儿护理指标的首次验证。
评估了33项孕产妇和新生儿指标。在DHS/MICS中已有的9项指标中,擦干或擦拭婴儿、测量出生体重、低出生体重以及婴儿性别(女性)的有效性比率在0.90至1.10之间。调查报告对器械助产、皮肤接触和早期开始母乳喂养的高估程度很高(2.04至4.83),而脐带护理指标则被大幅低估(0.14至0.22)。在目前DHS/MICS中未有的24项指标中,两项新生儿接触指标(袋鼠式护理1.00,入住新生儿病房1.01)在入院新生儿中的调查报告覆盖率很高且敏感性很高。其余指标表现不佳,有些指标的“不知道”回答率非常高。
我们的研究表明,即使对于阴道分娩的妇女缩短回忆期,通过出院调查问卷收集许多孕产妇和新生儿指标的有效性也很低。家庭调查已经面临负担过重的风险,一些特定的临床护理指标表现不佳且可能力度不足。鉴于全球约80%的分娩发生在医疗机构,还应探索常规登记以跟踪关键孕产妇和新生儿健康干预措施的覆盖率,特别是对于临床护理。